Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals ...

Trump's sweeping policy changes, cooling US Core CPI inflation data for December, a resilient economy, and a strong earnings ...

With multiple suitors circling and Trump framing the situation as a deal-making exercise, TikTok's U.S. future is still up in ...

Grail (GRAL) is jumping for a second straight day, climbing 6% today, after Oracle (ORCL) Chairman Larry Ellison on Tuesday said that blood tests that detect small tumor fragments could be used, in ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

OpenAI and SoftBank (OTCPK:SFTBY) will commit $19B each to the artificial intelligence-focused Stargate Project, The ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

The market's reaction to the news about Project Stargate was very positive with ARM's stock skyrocketing by as much as 16%.

Larry Ellison, the founder of Oracle (ORCL), is ending 2024 with a fortune of $213.3 billion, a big jump from the $145.5 billion he started the year with. Like Zuckerberg, Ellison benefited from a ...

Elon Musk is skeptical about Stargate, the AI joint venture that includes OpenAI, and in a rare occurrence, he may be right.

Absi Corp (NASDAQ:ABSI), Recursion Pharma (NASDAQ:RXRX), Schrodinger (NASDAQ:SDGR), and Certara (NASDAQ:CERT) are ...